Celsius (NASDAQ:CELH) PT Raised to $105.00

Celsius (NASDAQ:CELHGet Free Report) had its price target increased by investment analysts at Jefferies Financial Group from $98.00 to $105.00 in a report released on Monday. The brokerage presently has a “buy” rating on the stock. Jefferies Financial Group’s target price would indicate a potential upside of 21.57% from the stock’s previous close.

A number of other equities analysts have also issued reports on CELH. Bank of America lowered shares of Celsius from a “buy” rating to a “neutral” rating and set a $65.00 target price for the company. in a research report on Friday, January 19th. Morgan Stanley upped their price target on shares of Celsius from $65.00 to $75.00 and gave the company an “equal weight” rating in a report on Friday, March 1st. Piper Sandler upped their price target on shares of Celsius from $76.00 to $90.00 and gave the company an “overweight” rating in a report on Friday, March 1st. UBS Group upped their price target on shares of Celsius from $73.00 to $99.00 and gave the company a “buy” rating in a report on Friday, March 1st. Finally, Maxim Group upped their price target on shares of Celsius from $65.00 to $100.00 and gave the company a “buy” rating in a report on Friday, March 1st. Two investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, Celsius currently has a consensus rating of “Moderate Buy” and a consensus price target of $84.38.

Get Our Latest Research Report on CELH

Celsius Stock Down 3.5 %

CELH opened at $86.37 on Monday. The company has a 50 day moving average of $66.79 and a two-hundred day moving average of $61.09. Celsius has a 52-week low of $27.59 and a 52-week high of $99.62. The company has a market cap of $19.95 billion, a P/E ratio of 111.69, a P/E/G ratio of 2.71 and a beta of 1.87.

Celsius (NASDAQ:CELHGet Free Report) last posted its quarterly earnings results on Thursday, February 29th. The company reported $0.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.01. Celsius had a net margin of 17.21% and a return on equity of 131.58%. The firm had revenue of $347.44 million for the quarter, compared to analysts’ expectations of $326.77 million. During the same period in the prior year, the company posted $0.01 earnings per share. The firm’s quarterly revenue was up 95.2% on a year-over-year basis. Research analysts anticipate that Celsius will post 1.09 earnings per share for the current year.

Insider Activity

In other news, CEO John Fieldly sold 9,107 shares of the firm’s stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $93.13, for a total value of $848,134.91. Following the completion of the sale, the chief executive officer now directly owns 340,550 shares in the company, valued at $31,715,421.50. The sale was disclosed in a filing with the SEC, which is accessible through this link. In other Celsius news, CEO John Fieldly sold 9,107 shares of the business’s stock in a transaction dated Tuesday, January 2nd. The stock was sold at an average price of $93.13, for a total transaction of $848,134.91. Following the completion of the sale, the chief executive officer now directly owns 340,550 shares of the company’s stock, valued at approximately $31,715,421.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Nicholas Castaldo sold 165,000 shares of the company’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $83.33, for a total value of $13,749,450.00. Following the completion of the sale, the director now directly owns 352,864 shares of the company’s stock, valued at $29,404,157.12. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 1,120,568 shares of company stock worth $64,473,782. 2.70% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Celsius

A number of large investors have recently bought and sold shares of the company. Vanguard Group Inc. boosted its position in Celsius by 183.6% during the 4th quarter. Vanguard Group Inc. now owns 13,746,472 shares of the company’s stock worth $749,458,000 after acquiring an additional 8,899,873 shares during the last quarter. BlackRock Inc. boosted its holdings in shares of Celsius by 0.9% in the 1st quarter. BlackRock Inc. now owns 6,435,150 shares of the company’s stock valued at $355,091,000 after buying an additional 58,764 shares during the last quarter. Wellington Management Group LLP boosted its holdings in shares of Celsius by 212.2% in the 4th quarter. Wellington Management Group LLP now owns 3,393,586 shares of the company’s stock valued at $185,018,000 after buying an additional 2,306,598 shares during the last quarter. Eagle Asset Management Inc. boosted its holdings in shares of Celsius by 188.8% in the 4th quarter. Eagle Asset Management Inc. now owns 2,958,771 shares of the company’s stock valued at $161,312,000 after buying an additional 1,934,400 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its holdings in shares of Celsius by 424.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 2,793,210 shares of the company’s stock valued at $152,287,000 after buying an additional 2,261,046 shares during the last quarter. Institutional investors and hedge funds own 60.32% of the company’s stock.

About Celsius

(Get Free Report)

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

Featured Articles

Analyst Recommendations for Celsius (NASDAQ:CELH)

Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.